Intera Oncology, INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$221Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
507clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Louise Catherine Connell | New York, NY | Medical Oncology | $24,851.39 |
| Jason Castellanos | Philadelphia, PA | Surgery | $23,945.21 |
| Chandrasekhar Padmanabhan | Nashville, TN | Surgical Oncology | $19,761.81 |
| Nancy Kemeny | New York, NY | Medical Oncology | $18,750.00 |
| Devika Rao | Bronx, NY | Medical Oncology | $14,749.99 |
| Ryan Merkow | Chicago, IL | Surgical Oncology | $10,640.68 |
| Jonathan Mizrahi | Saint Louis, MO | Hematology & Oncology | $7,429.84 |
| Cornelius Thiels | Rochester, MN | Surgery | $5,791.07 |
| Alan Venook | San Francisco, CA | Medical Oncology | $2,500.00 |
| Nathan Bolton | New Orleans, LA | Surgical Oncology | $1,701.88 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.